Beam Therapeutics names Eric Foster chief commercial officer
BEAM•Beam Therapeutics appoints Eric Foster as chief commercial officer
Beam Therapeutics appointed Eric Foster as chief commercial officer to lead commercial strategy as programs move toward potential launches.
Foster most recently served as chief commercial officer at Ardelyx.
He previously led Horizon’s gout and ophthalmology units, overseeing franchises with USD 2.75 billion in net sales.
Earlier roles included senior vice president and U.S. general manager at Amgen, sales and marketing leadership at GlaxoSmithKline, and roles at Johnson & Johnson.
